ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors) (2021)
Bonifacio, L.; Ramacciotti, E.; Agati, L.; Vilar, F.; Tojal, A.; Souza, H.; Louzada Júnior, Paulo; Fonseca, Benedito Antonio Lopes da; Lopes, R.; Kallas, Esper Georges ; Bellíssimo-Rodrigues, Fernando
Source: Antimicrobial Resistance & Infection Control. Conference titles: International Conference on Prevention & Infection Control (ICPIC 2021). Unidades: FMRP, FM
Subjects: COVID-19, PACIENTES INTERNADOS, ESTUDOS MULTICÊNTRICOS, ESTUDOS PROSPECTIVOS, CITOCINAS, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFACIO, L. et al. Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors). Antimicrobial Resistance & Infection Control. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf. Acesso em: 05 nov. 2024. , 2021
APA
Bonifacio, L., Ramacciotti, E., Agati, L., Vilar, F., Tojal, A., Souza, H., et al. (2021). Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors). Antimicrobial Resistance & Infection Control. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Recuperado de https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf
NLM
Bonifacio L, Ramacciotti E, Agati L, Vilar F, Tojal A, Souza H, Louzada Júnior P, Fonseca BAL da, Lopes R, Kallas EG, Bellíssimo-Rodrigues F. Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors) [Internet]. Antimicrobial Resistance & Infection Control. 2021 ; 10 61.[citado 2024 nov. 05 ] Available from: https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf
Vancouver
Bonifacio L, Ramacciotti E, Agati L, Vilar F, Tojal A, Souza H, Louzada Júnior P, Fonseca BAL da, Lopes R, Kallas EG, Bellíssimo-Rodrigues F. Efficacy of ixekizumab vs. IL-2 vs. colchicine vs. standard of care for the treatment of hospitalized patients with COVID-19: preliminary results of a randomized clinical trial (struck: survival trial using cytokine inhibitors) [Internet]. Antimicrobial Resistance & Infection Control. 2021 ; 10 61.[citado 2024 nov. 05 ] Available from: https://aricjournal.biomedcentral.com/track/pdf/10.1186/s13756-021-00974-z.pdf
Artigo de periodico
Four-year adiposity change and remission of hypertension: an observational evaluation from the Longitudinal Study of Adult Health (ELSA-Brasil) (2020)
Guimaraes, Joanna M. N; Griep, Rosane H; Fonseca, Maria J. M; Duncan, Bruce B; Schmidt, Maria I; Mill, Jose G; Lotufo, Paulo A; Benseñor, Isabela Judith Martins ; Barreto, Sandhi M; Giatti, Luana
Source: Journal of human hypertension. Unidade: FM
Subjects: PERDA DE PESO, HIPERTENSÃO, CURA, ADIPOSIDADE, CIRCUNFERÊNCIA ABDOMINAL, ÍNDICE DE MASSA CORPORAL, ESTUDOS LONGITUDINAIS, ESTUDOS MULTICÊNTRICOS, ESTUDOS PROSPECTIVOS, ESTUDOS DE COORTES, SEGUIMENTOS, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARAES, Joanna M. N et al. Four-year adiposity change and remission of hypertension: an observational evaluation from the Longitudinal Study of Adult Health (ELSA-Brasil). Journal of human hypertension, v. 34, n. 1, p. 68-75, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41371-019-0289-5. Acesso em: 05 nov. 2024.
APA
Guimaraes, J. M. N., Griep, R. H., Fonseca, M. J. M., Duncan, B. B., Schmidt, M. I., Mill, J. G., et al. (2020). Four-year adiposity change and remission of hypertension: an observational evaluation from the Longitudinal Study of Adult Health (ELSA-Brasil). Journal of human hypertension, 34( 1), 68-75. doi:10.1038/s41371-019-0289-5
NLM
Guimaraes JMN, Griep RH, Fonseca MJM, Duncan BB, Schmidt MI, Mill JG, Lotufo PA, Benseñor IJM, Barreto SM, Giatti L. Four-year adiposity change and remission of hypertension: an observational evaluation from the Longitudinal Study of Adult Health (ELSA-Brasil) [Internet]. Journal of human hypertension. 2020 ; 34( 1): 68-75.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1038/s41371-019-0289-5
Vancouver
Guimaraes JMN, Griep RH, Fonseca MJM, Duncan BB, Schmidt MI, Mill JG, Lotufo PA, Benseñor IJM, Barreto SM, Giatti L. Four-year adiposity change and remission of hypertension: an observational evaluation from the Longitudinal Study of Adult Health (ELSA-Brasil) [Internet]. Journal of human hypertension. 2020 ; 34( 1): 68-75.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1038/s41371-019-0289-5
Artigo de periodico
Derivo embolization device for the treatment of intracranial aneurysms: a multicenter study of 183 aneurysms (2019)
Trivelato, Felipe Padovani; Abud, Daniel Giansante ; Ulhôa, Alexandre Cordeiro; Waihrich, Eduardo Siqueira; Abud, Thiago Giansante; Castro-Afonso, Luis Henrique de; Nakiri, Guilherme Seizem; Castro, Guilherme Duarte de; Parente, Bruno de Sousa Mendes; Silva, Rodrigo dos Santos; Manzato, Luciano Bambini; Bonadio, Lucas Eduardo; Viana, Dinark Conceição; Vanzin, José Ricardo; Baccin, Carlos Eduardo; Rezende, Marco Túlio Salles
Source: Stroke. Unidade: FMRP
Subjects: ANEURISMA, ANGIOGRAFIA, ESTUDOS MULTICÊNTRICOS, ESTUDOS PROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TRIVELATO, Felipe Padovani et al. Derivo embolization device for the treatment of intracranial aneurysms: a multicenter study of 183 aneurysms. Stroke, v. 50, n. 9, p. 2351-2358, 2019Tradução . . Disponível em: https://doi.org/10.1161/STROKEAHA.119.025407. Acesso em: 05 nov. 2024.
APA
Trivelato, F. P., Abud, D. G., Ulhôa, A. C., Waihrich, E. S., Abud, T. G., Castro-Afonso, L. H. de, et al. (2019). Derivo embolization device for the treatment of intracranial aneurysms: a multicenter study of 183 aneurysms. Stroke, 50( 9), 2351-2358. doi:10.1161/STROKEAHA.119.025407
NLM
Trivelato FP, Abud DG, Ulhôa AC, Waihrich ES, Abud TG, Castro-Afonso LH de, Nakiri GS, Castro GD de, Parente B de SM, Silva R dos S, Manzato LB, Bonadio LE, Viana DC, Vanzin JR, Baccin CE, Rezende MTS. Derivo embolization device for the treatment of intracranial aneurysms: a multicenter study of 183 aneurysms [Internet]. Stroke. 2019 ; 50( 9): 2351-2358.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1161/STROKEAHA.119.025407
Vancouver
Trivelato FP, Abud DG, Ulhôa AC, Waihrich ES, Abud TG, Castro-Afonso LH de, Nakiri GS, Castro GD de, Parente B de SM, Silva R dos S, Manzato LB, Bonadio LE, Viana DC, Vanzin JR, Baccin CE, Rezende MTS. Derivo embolization device for the treatment of intracranial aneurysms: a multicenter study of 183 aneurysms [Internet]. Stroke. 2019 ; 50( 9): 2351-2358.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1161/STROKEAHA.119.025407

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Funding Agencies

Indexado em

Non normalized affiliation